Inventor · disambiguated record
Anders Pedersen
Also filed as: PEDERSEN ANDERS · PEDERSEN ANDERS VAGNO
7 granted patents·3 pending applications·34 citations·filing 2008–2022
80Inventor score
Top patents by PatentIndex Score
10 records- 0186US9642809B2Controlled release pharmaceutical compositions for prolonged effectEGALET LTD·Filed 2014·Granted May 9, 2017·12 cites·27 claims
- 0285US8821928B2Controlled release pharmaceutical compositions for prolonged effectHEMMINGSEN PERNILLE HOYRUP·Filed 2008·Granted Sep 2, 2014·19 cites·27 claims
- 0376US10799482B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2019·Granted Oct 13, 2020·1 cites·12 claims
- 0476US10307403B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2018·Granted Jun 4, 2019·1 cites·17 claims
- 0574US10369136B2Polymorphic forms and processGALECTO BIOTECH AB·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 0664US2022257628A1Once-daily treatment of pulmonary fibrosisGALECTO BIOTECH AB·Filed 2022·Application pending·0 cites
- 0753US11406655B2Once-daily treatment of pulmonary fibrosisGALECTO BIOTECH AB·Filed 2015·Granted Aug 9, 2022·0 cites·5 claims
- 0850US2010291205A1Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuseEGALET AS·Filed 2008·Application pending·0 cites
- 0945US2022064204A1Amorphous form of 5-bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1h-1,2,3-triazol-1-yl]-1-thio-alpha-d-galactopyranosideGALECTO BIOTECH AB·Filed 2019·Application pending·0 cites
- 1037US10730902B21,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Aug 4, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Anders Pedersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →